Clinical Trial Update: Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT [Phase 2]

View source ↗

Summary

Phase 2 trial results assess the efficacy of low-dose post-transplant cyclophosphamide for preventing graft-versus-host disease in ambulatory allogeneic hematop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• post-transplant cyclophosphamide (cyclophosphamide)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Graft Versus Host Disease | Phase 2 | Status: COMPLETED